Natural compounds as a potential modifier of stem cells renewal: Comparative analysis

Eur J Pharmacol. 2023 Jan 5:938:175412. doi: 10.1016/j.ejphar.2022.175412. Epub 2022 Nov 24.

Abstract

Cancer stem cells (CSCs) are indispensable for development, progression, drug resistance, and tumor metastasis. Current cancer-directed interventions target targeting rapidly dividing cancer cells and slow dividing CSCs, which are the root cause of cancer origin and recurrence. The most promising targets include several self-renewal pathways involved in the maintenance and renewal of CSCs, such as the Wnt/β-Catenin, Sonic Hedgehog, Notch, Hippo, Autophagy, and Ferroptosis. In view of safety, natural compounds are coming to the front line of treatment modalities for modifying various signaling pathways simultaneously involved in maintaining CSCs. Therefore, targeting CSCs with natural compounds is a promising approach to treating various types of cancers. In view of this, here we provide a comprehensive update on the current status of natural compounds that effectively tune key self-renewal pathways of CSCs. In addition, we highlighted surface expression markers in several types of cancer. We also emphasize how natural compounds target these self-renewal pathways to reduce therapy resistance and cancer recurrence properties of CSCs, hence providing valuable cancer therapeutic strategies. The inclusion of nutraceuticals is believed to enhance the therapeutic efficacy of current cancer-directed interventions significantly.

Keywords: Cancer stem cells; Molecular pathways; Natural compounds; Self-renewal; Therapeutic agents.

Publication types

  • Review

MeSH terms

  • Biological Products* / pharmacology
  • Cell Self Renewal*
  • Humans
  • Neoplasms* / drug therapy
  • Neoplastic Stem Cells* / pathology
  • Signal Transduction*

Substances

  • Biological Products